CRISPR Therapeutics AG (CRSP)

NGM – Real Time Price. Currency in USD

53.82

-0.25 (-0.46%)

Market open: Aug 12, 2026, 1:10 PM EDT

53.80

-0.27 (-0.50%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

37M

371M

Cost of goods sold

-233M

-130M

-150M

-134M

Gross Profit

-229M

-92M

221M

-133M

Operating expenses (excl. COGS)

-339M

-374M

-444M

-540M

Operating Income

-568M

-467M

-223M

-673M

Non-operating income, total

-10M

104M

72M

23M

Pretax income

-578M

-363M

-151M

-651M

Equity in earnings

Taxes

-4M

-3M

325K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-582M

-366M

-154M

-650M

Discontinued operations

Net income

-582M

-366M

-154M

-650M

Dilution adjustment

Preferred dividends

CRISPR Therapeutics AG (CRSP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

CRISPR Therapeutics AG (CRSP)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

CRISPR Therapeutics AG (CRSP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

CRISPR Therapeutics AG (CRSP)

Income Statement (Annual)

Income Statement (Annual)